Walgreens Boots Alliance Inc (WBA) Shares Bought by Fulton Bank N.A.
Fulton Bank N.A. increased its holdings in Walgreens Boots Alliance Inc (NASDAQ:WBA) by 18.8% in the 3rd quarter, according to its most recent filing with the SEC. The institutional investor owned 5,761 shares of the pharmacy operator’s stock after buying an additional 912 shares during the quarter. Fulton Bank N.A.’s holdings in Walgreens Boots Alliance were worth $445,000 at the end of the most recent reporting period.
A number of other hedge funds and other institutional investors have also added to or reduced their stakes in WBA. Eqis Capital Management Inc. grew its stake in shares of Walgreens Boots Alliance by 11.5% during the 3rd quarter. Eqis Capital Management Inc. now owns 14,824 shares of the pharmacy operator’s stock valued at $1,145,000 after purchasing an additional 1,533 shares during the period. Hefty Wealth Partners grew its stake in shares of Walgreens Boots Alliance by 5,097.8% during the 3rd quarter. Hefty Wealth Partners now owns 9,616 shares of the pharmacy operator’s stock valued at $743,000 after purchasing an additional 9,431 shares during the period. Perpetual Ltd grew its stake in shares of Walgreens Boots Alliance by 22.4% during the 2nd quarter. Perpetual Ltd now owns 6,552 shares of the pharmacy operator’s stock valued at $513,000 after purchasing an additional 1,200 shares during the period. MPS Loria Financial Planners LLC bought a new stake in shares of Walgreens Boots Alliance during the 2nd quarter valued at about $457,000. Finally, Davidson Kempner Capital Management LP bought a new stake in shares of Walgreens Boots Alliance during the 2nd quarter valued at about $13,701,000. Institutional investors own 60.24% of the company’s stock.
Walgreens Boots Alliance Inc (NASDAQ WBA) opened at $71.05 on Thursday. The company has a quick ratio of 0.59, a current ratio of 1.07 and a debt-to-equity ratio of 0.45. Walgreens Boots Alliance Inc has a twelve month low of $63.82 and a twelve month high of $88.00. The company has a market capitalization of $69,503.16, a P/E ratio of 13.76, a P/E/G ratio of 1.25 and a beta of 1.22.
Walgreens Boots Alliance declared that its board has approved a share buyback program on Wednesday, October 25th that allows the company to repurchase $1.00 billion in outstanding shares. This repurchase authorization allows the pharmacy operator to repurchase shares of its stock through open market purchases. Shares repurchase programs are generally an indication that the company’s management believes its shares are undervalued.
The firm also recently declared a quarterly dividend, which will be paid on Tuesday, December 12th. Investors of record on Monday, November 13th will be issued a $0.40 dividend. The ex-dividend date is Friday, November 10th. This represents a $1.60 dividend on an annualized basis and a yield of 2.25%. Walgreens Boots Alliance’s dividend payout ratio is presently 42.33%.
In related news, Director William C. Foote sold 2,736 shares of the business’s stock in a transaction that occurred on Thursday, November 2nd. The stock was sold at an average price of $67.37, for a total value of $184,324.32. Following the transaction, the director now directly owns 16,415 shares of the company’s stock, valued at approximately $1,105,878.55. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, Director John Anthony Lederer purchased 20,000 shares of the stock in a transaction that occurred on Thursday, October 26th. The stock was acquired at an average cost of $67.00 per share, for a total transaction of $1,340,000.00. Following the completion of the acquisition, the director now owns 50,000 shares in the company, valued at approximately $3,350,000. The disclosure for this purchase can be found here. 14.80% of the stock is currently owned by insiders.
A number of equities research analysts have issued reports on WBA shares. Morgan Stanley downgraded Walgreens Boots Alliance from an “overweight” rating to an “equal weight” rating and cut their price target for the company from $95.00 to $85.00 in a research note on Friday, October 6th. BidaskClub upgraded Walgreens Boots Alliance from a “strong sell” rating to a “sell” rating in a research note on Friday, November 10th. Robert W. Baird reaffirmed an “outperform” rating and set a $80.00 price objective (down from $90.00) on shares of Walgreens Boots Alliance in a research report on Thursday, October 19th. They noted that the move was a valuation call. Citigroup lowered their price objective on Walgreens Boots Alliance from $95.00 to $81.00 and set a “buy” rating on the stock in a research report on Thursday, November 2nd. Finally, Zacks Investment Research cut Walgreens Boots Alliance from a “hold” rating to a “sell” rating in a research report on Tuesday, October 17th. One analyst has rated the stock with a sell rating, nine have assigned a hold rating and fourteen have given a buy rating to the stock. Walgreens Boots Alliance has an average rating of “Buy” and a consensus price target of $86.47.
TRADEMARK VIOLATION NOTICE: “Walgreens Boots Alliance Inc (WBA) Shares Bought by Fulton Bank N.A.” was first reported by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are viewing this piece of content on another publication, it was illegally copied and reposted in violation of US & international copyright and trademark law. The legal version of this piece of content can be viewed at https://www.thecerbatgem.com/2017/12/07/walgreens-boots-alliance-inc-wba-shares-bought-by-fulton-bank-n-a.html.
Walgreens Boots Alliance Company Profile
Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).
Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance Inc (NASDAQ:WBA).
Receive News & Ratings for Walgreens Boots Alliance Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance Inc and related companies with MarketBeat.com's FREE daily email newsletter.